Ataee Pedram, Karimi Avat, Eftekhari Kambiz
Liver and Digestive Research Center, Research Institute for Health Development, Department of Pediatric, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Department of Pediatric, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Case Rep Pediatr. 2020 Jan 29;2020:9634196. doi: 10.1155/2020/9634196. eCollection 2020.
Cockayne syndrome is an uncommon autosomal recessive disease characterized by microcephaly, abnormal growth, and pathologic premature aging. The purpose of this report is to evaluate liver failure in children with Cockayne syndrome following metronidazole administration. The first case was a 2-year-old boy with Cockayne syndrome. He had been treated with metronidazole for gastroenteritis. 48 hours after treatment initiation, he was hospitalized due to jaundice, intractable vomiting, and agitation. Unfortunately, he died of acute liver failure. The second case was a 5-year-old boy with Cockayne syndrome as well, who had been treated with amoxicillin and metronidazole for a dental infection. He developed jaundice, drowsiness, lethargy, and anorexia after treatment. At hospital, the child received supportive treatment, and his general condition gradually improved. The liver enzyme levels decreased. He was finally discharged in good general condition. The mortality after metronidazole consumption in patients with Cockayne syndrome due to liver failure is very high. The awareness of the dangers of using metronidazole in these patients is valuable.
科凯恩综合征是一种罕见的常染色体隐性疾病,其特征为小头畸形、生长异常和病理性早衰。本报告的目的是评估科凯恩综合征患儿在使用甲硝唑后出现肝衰竭的情况。首例病例为一名患有科凯恩综合征的2岁男孩。他因肠胃炎接受了甲硝唑治疗。治疗开始48小时后,他因黄疸、顽固性呕吐和烦躁不安而住院。不幸的是,他死于急性肝衰竭。第二例病例也是一名患有科凯恩综合征的5岁男孩,他因牙齿感染接受了阿莫西林和甲硝唑治疗。治疗后,他出现了黄疸、嗜睡、昏睡和厌食症状。在医院,该患儿接受了支持治疗,其一般状况逐渐改善。肝酶水平下降。他最终康复出院,身体状况良好。科凯恩综合征患者使用甲硝唑后因肝衰竭导致的死亡率非常高。认识到在这些患者中使用甲硝唑的危险性很有价值。